Oligonucleotides: Overcoming sustainability challenges with manufacturing
Oligonucleotides have the potential to transform medical treatments for diseases such as cancer and Alzheimer’s, but many obstacles impede the scale-up of manufacturing – with sustainability a key issue. CPI’s new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland could help to overcome many of these challenges.
